About Index Trending news
Lists
Pricing
Osprey Medical

Osprey Medical

Osprey Medical

MOsprey Medical develops and commercializes its propriety CINCOR™ Systemdesigned for the prevention of Contrast Induced Nephropathy.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding Show all
Post-IPO equity
$26,000,000
Venture capital
$25,000,000
Canaccord Genuity, Bill Potter
Employees

Team size

10+
Locations
HQ
Headquarters
$26,000,000 Post-IPO equity
Star Tribune , MassDevice

Osprey Medical raises $26M, plans to expand sales force

$25,000,000 Venture capital
Financial Review

Osprey Medical seeks $25m equity injection